TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2586502
log Bayes Factor = 0.14675
Chromosome 17   position 48,289,070  (GRCh37) Explore rs2586502 on Ensembl!
Variant rs2586502 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.693 0.307
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.697 0.303
T39.0 Salicylates
0.000 0.707 0.293
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.716 0.284
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.721 0.279
T39.1 4-Aminophenol derivatives
0.000 0.722 0.278
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.730 0.270
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.736 0.264
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.740 0.260
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.742 0.258
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.747 0.253
T40.2 Other opioids
0.000 0.749 0.251
T40.4 Other synthetic narcotics
0.000 0.750 0.250
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.752 0.248
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.757 0.243
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.763 0.237
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.766 0.234
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.772 0.228
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.774 0.226
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.775 0.225
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.780 0.220
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.780 0.220
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.782 0.218
T39.4 Antirheumatics, not elsewhere classified
0.000 0.783 0.217
T39.2 Pyrazolone derivatives
0.000 0.783 0.217
T40.5 Cocaine
0.000 0.783 0.217
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.785 0.215
T38.1 Thyroid hormones and substitutes
0.000 0.786 0.214
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.786 0.214
T36 Poisoning by systemic antibiotics
0.000 0.788 0.212
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.791 0.209
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.791 0.209
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.792 0.208
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.793 0.207
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.794 0.206
T40.1 Heroin
0.000 0.795 0.205
T43.6 Psychostimulants with abuse potential
0.000 0.795 0.205
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.796 0.204
T40.8 Lysergide [LSD]
0.000 0.796 0.204
T40.7 Cannabis (derivatives)
0.000 0.796 0.204
T40.0 Opium
0.000 0.796 0.204
T47.6 Antidiarrhoeal drugs
0.000 0.797 0.203
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.798 0.201
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.799 0.201
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.800 0.200
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.800 0.200
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.800 0.200
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.800 0.200
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.800 0.200
T44.0 Anticholinesterase agents
0.000 0.800 0.200
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.800 0.200
T50.1 Loop [high-ceiling] diuretics
0.000 0.801 0.198
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.805 0.195
T38.9 Other and unspecified hormone antagonists
0.000 0.806 0.194
T38.7 Androgens and anabolic congeners
0.000 0.806 0.194
T38.4 Oral contraceptives
0.000 0.806 0.194
T38.2 Antithyroid drugs
0.000 0.806 0.194
T47.4 Other laxatives
0.000 0.807 0.193
T50.8 Diagnostic agents
0.000 0.807 0.193
T43.9 Psychotropic drug, unspecified
0.000 0.807 0.193
T40.3 Methadone
0.000 0.808 0.192
T38.5 Other oestrogens and progestogens
0.000 0.808 0.192
T38.0 Glucocorticoids and synthetic analogues
0.000 0.809 0.191
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.811 0.189
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.811 0.189
T50.7 Analeptics and opioid receptor antagonists
0.000 0.813 0.187
T50.5 Appetite depressants
0.000 0.813 0.187
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.813 0.187
T50.0 Mineralocorticoids and their antagonists
0.000 0.813 0.187
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.814 0.186
T50.4 Drugs affecting uric acid metabolism
0.000 0.814 0.186
T47.2 Stimulant laxatives
0.000 0.814 0.185
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.815 0.185
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.815 0.185
T47.7 Emetics
0.000 0.815 0.185
T47.5 Digestants
0.000 0.815 0.185
T47.3 Saline and osmotic laxatives
0.000 0.815 0.185
T47.0 Histamine H(2)-receptor antagonists
0.000 0.816 0.184
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.816 0.184
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.817 0.183
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.818 0.182
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.818 0.182
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.818 0.182
T40.6 Other and unspecified narcotics
0.000 0.818 0.182
T42.0 Hydantoin derivatives
0.000 0.818 0.182
T43.2 Other and unspecified antidepressants
0.000 0.820 0.180
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.822 0.178
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.822 0.178
T46.7 Peripheral vasodilators
0.000 0.822 0.178
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.824 0.175
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.826 0.173
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.828 0.172
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.828 0.172
T42.1 Iminostilbenes
0.000 0.829 0.171
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.830 0.170
T42.2 Succinimides and oxazolidinediones
0.000 0.830 0.170
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.832 0.168
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.832 0.168
T37.5 Antiviral drugs
0.000 0.832 0.168
T37.4 Anthelminthics
0.000 0.832 0.168
T37.3 Other antiprotozoal drugs
0.000 0.832 0.168
T37.1 Antimycobacterial drugs
0.000 0.832 0.168
T37.0 Sulphonamides
0.000 0.832 0.168
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.832 0.167
T41.2 Other and unspecified general anaesthetics
0.000 0.833 0.167
T45.0 Antiallergic and antiemetic drugs
0.000 0.835 0.165
T41.5 Therapeutic gases
0.000 0.838 0.162
T41.4 Anaesthetic, unspecified
0.000 0.838 0.162
T41.3 Local anaesthetics
0.000 0.838 0.162
T41.1 Intravenous anaesthetics
0.000 0.838 0.162
T41.0 Inhaled anaesthetics
0.000 0.838 0.162
T48.5 Anti-common-cold drugs
0.000 0.839 0.161
T42.3 Barbiturates
0.000 0.842 0.158
T36.0 Penicillins
0.000 0.843 0.157
T49.9 Topical agent, unspecified
0.000 0.846 0.154
T49.8 Other topical agents
0.000 0.846 0.154
T49.7 Dental drugs, topically applied
0.000 0.846 0.154
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.846 0.154
T49.5 Ophthalmological drugs and preparations
0.000 0.846 0.154
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.846 0.154
T49.3 Emollients, demulcents and protectants
0.000 0.846 0.154
T49.2 Local astringents and local detergents
0.000 0.846 0.154
T49.1 Antipruritics
0.000 0.846 0.154
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.847 0.153
T48.4 Expectorants
0.000 0.847 0.153
T48.3 Antitussives
0.000 0.847 0.153
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.847 0.153
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.847 0.153
T48.0 Oxytocic drugs
0.000 0.847 0.153
T36.3 Macrolides
0.000 0.848 0.152
T36.9 Systemic antibiotic, unspecified
0.000 0.848 0.152
T36.7 Antifungal antibiotics, systemically used
0.000 0.848 0.152
T36.6 Rifamycins
0.000 0.848 0.152
T36.5 Aminoglycosides
0.000 0.848 0.152
T36.2 Chloramphenicol group
0.000 0.848 0.152
T36.8 Other systemic antibiotics
0.000 0.850 0.150
T46.1 Calcium-channel blockers
0.000 0.851 0.149
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.852 0.148
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.852 0.148
T45.8 Other primarily systemic and haematological agents
0.000 0.852 0.148
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.852 0.148
T45.6 Fibrinolysis-affecting drugs
0.000 0.852 0.148
T45.3 Enzymes, not elsewhere classified
0.000 0.852 0.148
T36.4 Tetracyclines
0.000 0.853 0.147
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.853 0.147
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.855 0.145
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.855 0.144
T45.4 Iron and its compounds
0.000 0.859 0.140
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.863 0.137
T45.5 Anticoagulants
0.000 0.864 0.135
T45.2 Vitamins, not elsewhere classified
0.000 0.867 0.133
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.876 0.123
T42.4 Benzodiazepines
0.000 0.901 0.099
E21.0 Primary hyperparathyroidism
0.056 0.944 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.055 0.945 0.000
E20-E35 Disorders of other endocrine glands
0.054 0.946 0.000
E22 Hyperfunction of pituitary gland
0.048 0.952 0.000
E34 Other endocrine disorders
0.047 0.953 0.000
E27 Other disorders of adrenal gland
0.047 0.953 0.000
E29 Testicular dysfunction
0.046 0.954 0.000
E23 Hypofunction and other disorders of pituitary gland
0.045 0.955 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.044 0.956 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.043 0.957 0.000
E21.3 Hyperparathyroidism, unspecified
0.043 0.957 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.043 0.957 0.000
E27.8 Other specified disorders of adrenal gland
0.042 0.958 0.000
E20 Hypoparathyroidism
0.042 0.958 0.000
E26 Hyperaldosteronism
0.041 0.959 0.000
E29.1 Testicular hypofunction
0.041 0.959 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.040 0.960 0.000
E24 Cushing's syndrome
0.040 0.960 0.000
E21.4 Other specified disorders of parathyroid gland
0.039 0.961 0.000
E22.1 Hyperprolactinaemia
0.039 0.961 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.039 0.961 0.000
E30 Disorders of puberty, not elsewhere classified
0.039 0.961 0.000
E34.0 Carcinoid syndrome
0.038 0.962 0.000
E32 Diseases of thymus
0.038 0.962 0.000
E34.8 Other specified endocrine disorders
0.037 0.963 0.000
E31 Polyglandular dysfunction
0.037 0.963 0.000
E34.9 Endocrine disorder, unspecified
0.037 0.963 0.000
E25 Adrenogenital disorders
0.037 0.963 0.000
E21.2 Other hyperparathyroidism
0.036 0.963 0.000
E23.0 Hypopituitarism
0.036 0.964 0.000
E27.1 Primary adrenocortical insufficiency
0.036 0.964 0.000
E27.2 Addisonian crisis
0.035 0.965 0.000
E34.3 Short stature, not elsewhere classified
0.035 0.965 0.000
E22.8 Other hyperfunction of pituitary gland
0.034 0.965 0.000
E34.5 Androgen resistance syndrome
0.034 0.966 0.000
E34.4 Constitutional tall stature
0.034 0.966 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.034 0.966 0.000
E34.1 Other hypersecretion of intestinal hormones
0.034 0.966 0.000
E27.5 Adrenomedullary hyperfunction
0.034 0.966 0.000
E27.0 Other adrenocortical overactivity
0.034 0.966 0.000
E23.2 Diabetes insipidus
0.033 0.967 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.033 0.967 0.000
E28 Ovarian dysfunction
0.033 0.967 0.000
E23.6 Other disorders of pituitary gland
0.033 0.967 0.000
E29.8 Other testicular dysfunction
0.033 0.967 0.000
E29.0 Testicular hyperfunction
0.033 0.967 0.000
E24.2 Drug-induced Cushing's syndrome
0.033 0.967 0.000
E23.7 Disorder of pituitary gland, unspecified
0.033 0.967 0.000
E29.9 Testicular dysfunction, unspecified
0.032 0.968 0.000
E23.1 Drug-induced hypopituitarism
0.032 0.968 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.032 0.968 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.032 0.968 0.000
E20.9 Hypoparathyroidism, unspecified
0.032 0.968 0.000
E20.1 Pseudohypoparathyroidism
0.031 0.969 0.000
E26.9 Hyperaldosteronism, unspecified
0.031 0.969 0.000
E26.0 Primary hyperaldosteronism
0.030 0.969 0.000
E20.8 Other hypoparathyroidism
0.030 0.970 0.000
E20.0 Idiopathic hypoparathyroidism
0.030 0.970 0.000
E22.0 Acromegaly and pituitary gigantism
0.030 0.970 0.000
E26.8 Other hyperaldosteronism
0.029 0.970 0.000
E26.1 Secondary hyperaldosteronism
0.029 0.970 0.000
E24.0 Pituitary-dependent Cushing's disease
0.029 0.971 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.029 0.971 0.000
E24.3 Ectopic ACTH syndrome
0.029 0.971 0.000
E24.1 Nelson's syndrome
0.029 0.971 0.000
E30.9 Disorder of puberty, unspecified
0.028 0.972 0.000
E30.8 Other disorders of puberty
0.028 0.972 0.000
E30.1 Precocious puberty
0.028 0.972 0.000
E30.0 Delayed puberty
0.028 0.972 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.028 0.972 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.028 0.972 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.028 0.972 0.000
E32.8 Other diseases of thymus
0.027 0.973 0.000
E32.1 Abscess of thymus
0.027 0.973 0.000
E32.0 Persistent hyperplasia of thymus
0.027 0.973 0.000
E24.8 Other Cushing's syndrome
0.027 0.973 0.000
E31.9 Polyglandular dysfunction, unspecified
0.027 0.973 0.000
E31.8 Other polyglandular dysfunction
0.027 0.973 0.000
E31.1 Polyglandular hyperfunction
0.027 0.973 0.000
E25.9 Adrenogenital disorder, unspecified
0.027 0.973 0.000
E25.8 Other adrenogenital disorders
0.027 0.973 0.000
E32.9 Disease of thymus, unspecified
0.026 0.974 0.000
E24.9 Cushing's syndrome, unspecified
0.025 0.974 0.000
E31.0 Autoimmune polyglandular failure
0.025 0.974 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.025 0.975 0.000
E28.9 Ovarian dysfunction, unspecified
0.024 0.976 0.000
E28.8 Other ovarian dysfunction
0.024 0.976 0.000
E28.1 Androgen excess
0.024 0.976 0.000
E28.0 Oestrogen excess
0.024 0.976 0.000
E27.9 Disorder of adrenal gland, unspecified
0.024 0.976 0.000
E28.3 Primary ovarian failure
0.023 0.976 0.000
N85.4 Malposition of uterus
0.000 0.981 0.019
E28.2 Polycystic ovarian syndrome
0.019 0.981 0.000
R91 Abnormal findings on diagnostic imaging of lung
0.013 0.987 0.000
G30.9 Alzheimer's disease, unspecified
0.000 0.994 0.006
I49.3 Ventricular premature depolarisation
0.006 0.994 0.000
Z91.0 Personal history of allergy, other than to drugs and biological substances
0.005 0.995 0.000
K56.2 Volvulus
0.000 0.995 0.005
I24.9 Acute ischaemic heart disease, unspecified
0.000 0.995 0.005
H81 Disorders of vestibular function
0.005 0.995 0.000
H81.0 Meniere's disease
0.005 0.995 0.000
H81.2 Vestibular neuronitis
0.005 0.995 0.000
H81.9 Disorder of vestibular function, unspecified
0.004 0.996 0.000
H81.1 Benign paroxysmal vertigo
0.004 0.996 0.000
G24.9 Dystonia, unspecified
0.000 0.996 0.004
H81.3 Other peripheral vertigo
0.004 0.996 0.000
H53.2 Diplopia
0.000 0.996 0.004
H81.8 Other disorders of vestibular function
0.004 0.996 0.000
H81.4 Vertigo of central origin
0.004 0.996 0.000
G30 Alzheimer's disease
0.000 0.996 0.004
I24 Other acute ischaemic heart diseases
0.000 0.996 0.004
G24 Dystonia
0.000 0.996 0.004
F20.9 Schizophrenia, unspecified
0.000 0.996 0.004
I24.8 Other forms of acute ischaemic heart disease
0.000 0.996 0.004
F20.0 Paranoid schizophrenia
0.000 0.996 0.003
M19.01 Primary arthrosis of other joints (Shoulder region)
0.000 0.997 0.003
G24.8 Other dystonia
0.000 0.997 0.003
F20 Schizophrenia
0.000 0.997 0.003
M19.03 Primary arthrosis of other joints (Forearm)
0.000 0.997 0.003
R19.5 Other fecal abnormalities
0.000 0.997 0.003
G30.1 Alzheimer's disease with late onset
0.000 0.997 0.003
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.000 0.997 0.003
Y43.3 Other antineoplastic drugs
0.000 0.997 0.003
D86.9 Sarcoidosis, unspecified
0.000 0.997 0.003
H26.8 Other specified cataract
0.003 0.997 0.000
Z88.2 Personal history of allergy to sulphonamides
0.003 0.997 0.000
Y43 Primarily systemic agents
0.000 0.997 0.003
Y43.0 Antiallergic and antiemetic drugs
0.000 0.997 0.003
G24.0 Drug-induced dystonia
0.000 0.997 0.003
G30.0 Alzheimer's disease with early onset
0.000 0.997 0.003
D86 Sarcoidosis
0.000 0.997 0.003
D86.0 Sarcoidosis of lung
0.000 0.997 0.003
Y43.1 Antineoplastic antimetabolites
0.000 0.997 0.003
F05.9 Delirium, unspecified
0.000 0.997 0.003
M19.07 Primary arthrosis of other joints (Ankle and foot)
0.000 0.997 0.003
K76.8 Other specified diseases of liver
0.000 0.997 0.003
D86.8 Sarcoidosis of other and combined sites
0.000 0.997 0.003
G30.8 Other Alzheimer's disease
0.000 0.997 0.003
M19.0 Primary arthrosis of other joints
0.000 0.997 0.003
F20.2 Catatonic schizophrenia
0.000 0.997 0.003
Y43.4 Immunosuppressive agents
0.000 0.997 0.003
G24.5 Blepharospasm
0.000 0.997 0.003
M19.06 Primary arthrosis of other joints-Lower leg
0.000 0.997 0.003
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.000 0.997 0.003
G24.3 Spasmodic torticollis
0.000 0.997 0.003
G24.4 Idiopathic orofacial dystonia
0.000 0.997 0.003
G24.2 Idiopathic nonfamilial dystonia
0.000 0.997 0.003
I24.1 Dressler's syndrome
0.000 0.997 0.003
G24.1 Idiopathic familial dystonia
0.000 0.997 0.003
I22.9 Subsequent myocardial infarction of unspecified site
0.000 0.997 0.003
F20.8 Other schizophrenia
0.000 0.997 0.003
F20.5 Residual schizophrenia
0.000 0.997 0.003
F00.9 Dementia in Alzheimer's disease, unspecified
0.000 0.997 0.003
F20.6 Simple schizophrenia
0.000 0.997 0.003
F20.4 Postschizophrenic depression
0.000 0.997 0.003
F20.3 Undifferentiated schizophrenia
0.000 0.997 0.003
F20.1 Hebephrenic schizophrenia
0.000 0.997 0.003
G25.3 Myoclonus
0.000 0.997 0.003
D86.3 Sarcoidosis of skin
0.000 0.997 0.003
N05.9 Unspecified
0.003 0.997 0.000
Y43.2 Antineoplastic natural products
0.000 0.997 0.002
M19.02 Primary arthrosis of other joints (Upper arm)
0.000 0.997 0.002
Y43.9 Primarily systemic agent, unspecified
0.000 0.997 0.002
Y43.8 Other primarily systemic agents, not elsewhere classified
0.000 0.997 0.002
Y43.6 Enzymes, not elsewhere classified
0.000 0.997 0.002
Y43.5 Acidifying and alkalising agents
0.000 0.997 0.002
G20-G26 Extrapyramidal and movement disorders
0.000 0.997 0.003
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)
0.000 0.998 0.002
F45.8 Other somatoform disorders
0.002 0.998 0.000
G20 Parkinson's disease
0.000 0.998 0.002
J43.9 Emphysema, unspecified
0.002 0.998 0.000
G25 Other extrapyramidal and movement disorders
0.000 0.998 0.002
M19.09 Primary arthrosis of other joints (Site unspecified)
0.000 0.998 0.002
D86.1 Sarcoidosis of lymph nodes
0.000 0.998 0.002
Z88.5 Personal history of allergy to narcotic agent
0.002 0.998 0.000
N05 Unspecified nephritic syndrome
0.002 0.998 0.000
N05.1 Focal and segmental glomerular lesions
0.002 0.998 0.000
M19.08 Primary arthrosis of other joints (Other)
0.000 0.998 0.002
E83.5 Disorders of calcium metabolism
0.002 0.998 0.000
H93.1 Tinnitus
0.000 0.998 0.002
O82.0 Delivery by elective Caesarean section
0.000 0.998 0.002
R73.0 Abnormal glucose tolerance test
0.002 0.998 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.000 0.998 0.002
F29 Unspecified nonorganic psychosis
0.000 0.998 0.002
F25 Schizoaffective disorders
0.000 0.998 0.002
M19.00 Primary arthrosis of other joints (Multiple sites)
0.000 0.998 0.002
G25.2 Other specified forms of tremor
0.000 0.998 0.002
N05.7 Diffuse crescentic glomerulonephritis
0.002 0.998 0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)
0.002 0.998 0.000
F25.0 Schizoaffective disorder, manic type
0.000 0.998 0.002
N86 Erosion and ectropion of cervix uteri
0.002 0.998 0.000
S82.40 Fracture of fibula alone (closed)
0.002 0.998 0.000
C54.1 Endometrium
0.000 0.998 0.002
C67.6 Ureteric orifice
0.000 0.998 0.002
C69.3 Choroid
0.002 0.998 0.000
H40.2 Primary angle-closure glaucoma
0.002 0.998 0.000
N05.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.998 0.002
N05.8 Other
0.002 0.998 0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.000 0.998 0.002
G22 Parkinsonism in diseases classified elsewhere
0.000 0.998 0.002
J32.0 Chronic maxillary sinusitis
0.002 0.998 0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.998 0.000
F00 Dementia in Alzheimer's disease
0.000 0.998 0.002
G23 Other degenerative diseases of basal ganglia
0.000 0.998 0.002
G25.5 Other chorea
0.000 0.998 0.002
B02.9 Zoster without complication
0.000 0.998 0.002
F05 Delirium, not induced by alcohol and other psychoactive substances
0.000 0.998 0.002
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
0.002 0.998 0.000
G25.6 Drug-induced tics and other tics of organic origin
0.000 0.998 0.002
G25.4 Drug-induced chorea
0.000 0.998 0.002
F25.1 Schizoaffective disorder, depressive type
0.000 0.998 0.002
H47.3 Other disorders of optic disk
0.000 0.998 0.002
N05.6 Dense deposit disease
0.002 0.998 0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.002 0.998 0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.998 0.000
N05.0 Minor glomerular abnormality
0.002 0.998 0.000
M54.57 Low back pain (Lumbosacral region)
0.002 0.998 0.000
G25.1 Drug-induced tremor
0.000 0.998 0.002
I21.0 Acute transmural myocardial infarction of anterior wall
0.000 0.998 0.002
S70.9 Superficial injury of hip and thigh, unspecified
0.000 0.998 0.002
I22 Subsequent myocardial infarction
0.000 0.998 0.002
C67.5 Bladder neck
0.000 0.998 0.002
F05.8 Other delirium
0.000 0.998 0.002
N85.0 Endometrial glandular hyperplasia
0.000 0.998 0.002
G21 Secondary Parkinsonism
0.000 0.998 0.002
M00.96 Pyogenic arthritis, unspecified (Lower leg)
0.002 0.998 0.000
N60.3 Fibrosclerosis of breast
0.002 0.998 0.000
F28 Other nonorganic psychotic disorders
0.000 0.998 0.002
F24 Induced delusional disorder
0.000 0.998 0.002
C67 Malignant neoplasm of bladder
0.000 0.998 0.002
F21 Schizotypal disorder
0.000 0.998 0.002
F00.2 Dementia in Alzheimer's disease, atypical or mixed type
0.000 0.998 0.002
F25.8 Other schizoaffective disorders
0.000 0.998 0.002
D35.1 Parathyroid gland
0.002 0.998 0.000
F25.2 Schizoaffective disorder, mixed type
0.000 0.998 0.002
G23.8 Other specified degenerative diseases of basal ganglia
0.000 0.998 0.002
C67.1 Dome of bladder
0.000 0.998 0.002
C90.0 Multiple myeloma
0.002 0.998 0.000
G25.0 Essential tremor
0.000 0.998 0.002
N60.0 Solitary cyst of breast
0.002 0.998 0.000
C67.9 Bladder, unspecified
0.000 0.998 0.002
F00.1 Dementia in Alzheimer's disease with late onset
0.000 0.998 0.002
F25.9 Schizoaffective disorder, unspecified
0.000 0.998 0.002
G25.9 Extrapyramidal and movement disorder, unspecified
0.000 0.998 0.002
M88.9 Paget's disease of bone, unspecified
0.002 0.998 0.000
N85 Other noninflammatory disorders of uterus, except cervix
0.000 0.998 0.002
C67.3 Anterior wall of bladder
0.000 0.998 0.002
F40.2 Specific (isolated) phobias
0.002 0.998 0.000
G23.9 Degenerative disease of basal ganglia, unspecified
0.000 0.998 0.002
G23.3 Multiple system atrophy, cerebellar type
0.000 0.998 0.002
G23.2 Striatonigral degeneration
0.000 0.998 0.002
G23.0 Hallervorden-Spatz disease
0.000 0.998 0.002
N60.8 Other benign mammary dysplasias
0.002 0.998 0.000
G25.8 Other specified extrapyramidal and movement disorders
0.000 0.998 0.002
I22.1 Subsequent myocardial infarction of inferior wall
0.000 0.998 0.002
F23 Acute and transient psychotic disorders
0.000 0.998 0.002
C67.0 Trigone of bladder
0.000 0.998 0.002
H40.5 Glaucoma secondary to other eye disorders
0.002 0.998 0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid
0.000 0.998 0.002
M19.04 Primary arthrosis of other joints (Hand)
0.000 0.998 0.001
E53.9 Vitamin B deficiency, unspecified
0.002 0.998 0.000
N60 Benign mammary dysplasia
0.002 0.998 0.000
F00.0 Dementia in Alzheimer's disease with early onset
0.000 0.998 0.002
C69 Malignant neoplasm of eye and adnexa
0.002 0.998 0.000
E53 Deficiency of other B group vitamins
0.002 0.998 0.000
I22.8 Subsequent myocardial infarction of other sites
0.000 0.998 0.002
E53.8 Deficiency of other specified B group vitamins
0.002 0.998 0.000
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
0.000 0.998 0.001
S02.40 Fracture of malar and maxillary bones (closed)
0.000 0.998 0.002
F45.3 Somatoform autonomic dysfunction
0.002 0.998 0.000
G21.8 Other secondary Parkinsonism
0.000 0.998 0.001
G21.3 Postencephalitic Parkinsonism
0.000 0.998 0.001
G21.2 Secondary Parkinsonism due to other external agents
0.000 0.998 0.001
F45 Somatoform disorders
0.002 0.998 0.000
C67.8 Overlapping lesion of bladder
0.000 0.998 0.002
C67.7 Urachus
0.000 0.998 0.001
G21.1 Other drug-induced secondary Parkinsonism
0.000 0.998 0.001
F22 Persistent delusional disorders
0.000 0.998 0.002
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)
0.001 0.998 0.000
C67.4 Posterior wall of bladder
0.000 0.998 0.002
C69.0 Conjunctiva
0.002 0.998 0.000
F05.1 Delirium superimposed on dementia
0.000 0.998 0.001
G21.0 Malignant neuroleptic syndrome
0.000 0.998 0.001
N85.5 Inversion of uterus
0.000 0.998 0.002
M89.9 Disorder of bone, unspecified
0.002 0.998 0.000
N20.2 Calculus of kidney with calculus of ureter
0.000 0.998 0.002
C69.2 Retina
0.001 0.998 0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
0.000 0.998 0.001
G21.4 Vascular parkinsonism
0.000 0.998 0.001
H93.8 Other specified disorders of ear
0.000 0.998 0.002
M54.99 Dorsalgia, unspecified (Site unspecified)
0.002 0.998 0.000
M88.99 Paget's disease of bone, unspecified (Site unspecified)
0.001 0.998 0.000
M88.98 Paget's disease of bone, unspecified (Other)
0.001 0.998 0.000
M88.97 Paget's disease of bone, unspecified (Ankle and foot)
0.001 0.998 0.000
M88.96 Paget's disease of bone, unspecified (Lower leg)
0.001 0.998 0.000
M88.94 Paget's disease of bone, unspecified (Hand)
0.001 0.998 0.000
M88.93 Paget's disease of bone, unspecified (Forearm)
0.001 0.998 0.000
M88.92 Paget's disease of bone, unspecified (Upper arm)
0.001 0.998 0.000
M88.91 Paget's disease of bone, unspecified (Shoulder region)
0.001 0.998 0.000
C69.4 Ciliary body
0.001 0.998 0.000
G21.9 Secondary Parkinsonism, unspecified
0.000 0.998 0.001
I22.0 Subsequent myocardial infarction of anterior wall
0.000 0.998 0.001
N60.2 Fibroadenosis of breast
0.002 0.998 0.000
N60.1 Diffuse cystic mastopathy
0.002 0.998 0.000
N85.3 Subinvolution of uterus
0.000 0.998 0.001
S40.9 Superficial injury of shoulder and upper arm, unspecified
0.002 0.998 0.000
F99 Mental disorder, not otherwise specified
0.002 0.998 0.000
N85.6 Intra-uterine synechiae
0.000 0.998 0.001
C62.9 Testis, unspecified
0.000 0.998 0.002
F23.2 Acute schizophrenia-like psychotic disorder
0.000 0.998 0.001
M89.96 Disorder of bone, unspecified (Lower leg)
0.001 0.998 0.000
F23.8 Other acute and transient psychotic disorders
0.000 0.998 0.001
M00.9 Pyogenic arthritis, unspecified
0.001 0.998 0.000
M89.98 Disorder of bone, unspecified (Other)
0.001 0.998 0.000
C69.8 Overlapping lesion of eye and adnexa
0.001 0.998 0.000
C69.6 Orbit
0.001 0.998 0.000
C69.5 Lachrymal gland and duct
0.001 0.998 0.000
C69.1 Cornea
0.001 0.998 0.000
F23.3 Other acute predominantly delusional psychotic disorders
0.000 0.998 0.001
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
0.000 0.998 0.001
I21.1 Acute transmural myocardial infarction of inferior wall
0.000 0.998 0.002
N85.7 Haematometra
0.000 0.998 0.001
H93 Other disorders of ear, not elsewhere classified
0.000 0.998 0.001
M89.94 Disorder of bone, unspecified (Hand)
0.001 0.998 0.000
M89.93 Disorder of bone, unspecified (Forearm)
0.001 0.998 0.000
M89.90 Disorder of bone, unspecified (Multiple sites)
0.001 0.998 0.000
C69.9 Eye, unspecified
0.001 0.998 0.000
E53.1 Pyridoxine deficiency
0.001 0.998 0.000
E53.0 Riboflavin deficiency
0.001 0.998 0.000
F05.0 Delirium not superimposed on dementia, so described
0.000 0.999 0.001
E50-E64 Other nutritional deficiencies
0.001 0.999 0.000
M00.95 Pyogenic arthritis, unspecified (Pelvic region and thigh)
0.001 0.999 0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)
0.001 0.999 0.000
F45.4 Persistent somatoform pain disorder
0.001 0.999 0.000
F45.1 Undifferentiated somatoform disorder
0.001 0.999 0.000
N60.9 Benign mammary dysplasia, unspecified
0.001 0.999 0.000
N85.1 Endometrial adenomatous hyperplasia
0.000 0.999 0.001
R22.4 Localised swelling, mass and lump, lower limb
0.000 0.999 0.001
S70.8 Other superficial injuries of hip and thigh
0.000 0.999 0.001
H80-H83 Diseases of inner ear
0.001 0.999 0.000
F22.8 Other persistent delusional disorders
0.000 0.999 0.001
M00.99 Pyogenic arthritis, unspecified (Site unspecified)
0.001 0.999 0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)
0.001 0.999 0.000
M89.91 Disorder of bone, unspecified (Shoulder region)
0.001 0.999 0.000
F45.2 Hypochondriacal disorder
0.001 0.999 0.000
F45.0 Somatisation disorder
0.001 0.999 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.